Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP

Clinical trial NCT07599111 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07599111
Sponsor: Zhou Chengzhi
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumonitis, Interstitial Immune Checkpoint Inhibitors (ICIs)Mesenchymal Stem Cells Exosomes

Start date: 2026-04-01
Primary completion: 2028-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.